Zhong, H

Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. [electronic resource] - Cancer research Mar 2000 - 1541-5 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

0008-5472


Carrier Proteins
Chromones--pharmacology
Culture Media, Serum-Free--pharmacology
DNA-Binding Proteins--biosynthesis
Endothelial Growth Factors--biosynthesis
Enzyme Inhibitors--pharmacology
Enzyme-Linked Immunosorbent Assay
Epidermal Growth Factor--genetics
Humans
Hypoxia--physiopathology
Hypoxia-Inducible Factor 1
Hypoxia-Inducible Factor 1, alpha Subunit
Immunophilins--genetics
Lymphokines--biosynthesis
Male
Morpholines--pharmacology
Neovascularization, Pathologic--metabolism
Nuclear Proteins--biosynthesis
PTEN Phosphohydrolase
Phosphatidylinositol 3-Kinases--genetics
Phosphoinositide-3 Kinase Inhibitors
Phosphoric Monoester Hydrolases--genetics
Phosphotransferases (Alcohol Group Acceptor)
Prostatic Neoplasms--drug therapy
Protein Serine-Threonine Kinases
Proto-Oncogene Proteins--genetics
Proto-Oncogene Proteins c-akt
Signal Transduction--drug effects
TOR Serine-Threonine Kinases
Tetradecanoylphorbol Acetate--pharmacology
Transcription Factors
Tumor Cells, Cultured--drug effects
Tumor Suppressor Proteins
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors